Citation: | Branch of Organ Transplantation of Chinese Medical Association. Technical specifcation for clinical application of immunosuppressive agents in organ transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(3): 213-226. doi: 10.3969/j.issn.1674-7445.2019.03.001 |
[1] |
DJAMALI A, TURC-BARON C, PORTALES P, et al. Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring[J]. Transplantation, 2000, 69(5):799-805. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_LWW2017052520706396
|
[2] |
UBER WE, UBER LA, VANBAKEL AB, et al. CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications[J]. Transplant Proc, 2004, 36(10):3245-3249. doi: 10.1016/j.transproceed.2004.11.099
|
[3] |
石炳毅, 郑树森, 刘永峰.中国器官移植临床诊疗指南[M].北京:人民卫生出版社, 2017.
|
[4] |
WANG X, QIN X, WANG Y, et al. Controlled-dose versus fixed-dose mycophenolate mofetil for kidney transplant recipients: a systematic review and Meta-analysis of randomized controlled trials[J]. Transplantation, 2013, 96(4):361-367. DOI: 10.1097/TP.0b013e31828c6dc7.
|
[5] |
BRENNAN DC, LEGENDRE C, PATEL D, et al. Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials[J]. Am J Transplant, 2011, 11(11):2453-2462. DOI: 10.1111/j.1600-6143.2011.03674.x.
|
[6] |
VEROUX M, TALLARITA T, CORONA D, et al. Sirolimus in solid organ transplantation: current therapies and new frontiers[J]. Immunotherapy, 2011, 3(12):1487-1497. DOI: 10.2217/imt.11.143.
|
[7] |
THOMUSCH O, WIESENER M, OPGENOORTH M, et al. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial[J]. Lancet, 2016, 388(10063):3006-3016.DOI: 10.1016/S0140-6736(16)32187-0.
|
[8] |
陈实.移植学[M].北京:人民卫生出版社, 2011.
|
[9] |
AITHAL GP, WATKINS PB, ANDRADE RJ, et al. Case definition and phenotype standardization in drug-induced liver injury[J]. Clin Pharmacol Ther, 2011, 89(6):806-815. DOI: 10.1038/clpt.2011.58.
|
[10] |
何晓顺, 朱晓峰.多器官移植与器官联合移植[M].广州:广东科技出版社, 2009.
|
[11] |
USUI J, YAMAGATA K, IMAI E, et al. Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version[J]. Clin Exp Nephrol, 2016, 20(6):827-831. DOI: 10.1007/s10157-016-1334-0.
|